ATE221200T1 - Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten - Google Patents
Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patientenInfo
- Publication number
- ATE221200T1 ATE221200T1 AT94914094T AT94914094T ATE221200T1 AT E221200 T1 ATE221200 T1 AT E221200T1 AT 94914094 T AT94914094 T AT 94914094T AT 94914094 T AT94914094 T AT 94914094T AT E221200 T1 ATE221200 T1 AT E221200T1
- Authority
- AT
- Austria
- Prior art keywords
- autoantibodies
- autoantigen
- detection
- patients
- diabetes
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 abstract 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 abstract 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4888693A | 1993-04-16 | 1993-04-16 | |
| PCT/US1994/003896 WO1994024564A1 (en) | 1993-04-16 | 1994-04-08 | Methods for diabetes susceptibility assessment in asymptomatic patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE221200T1 true ATE221200T1 (de) | 2002-08-15 |
Family
ID=21956973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94914094T ATE221200T1 (de) | 1993-04-16 | 1994-04-08 | Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6316209B1 (de) |
| EP (1) | EP0693183B1 (de) |
| JP (1) | JP3425149B2 (de) |
| AT (1) | ATE221200T1 (de) |
| DE (1) | DE69431051T2 (de) |
| WO (1) | WO1994024564A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE221200T1 (de) | 1993-04-16 | 2002-08-15 | Univ California | Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten |
| AU4482896A (en) * | 1995-01-31 | 1996-08-21 | Novo Nordisk A/S | A method of diagnosing preclinical diabetes |
| US7189516B2 (en) * | 2001-08-17 | 2007-03-13 | Luminex Corporation | Method for characterizing autoimmune disorders |
| IN2014DN09410A (de) | 2012-04-13 | 2015-07-17 | Diabetomics Llc | |
| GB201509575D0 (en) * | 2015-06-03 | 2015-07-15 | King S College London | Diagnostic target |
| US11173136B2 (en) | 2018-01-10 | 2021-11-16 | Brightseed, Inc. | Method for modulating metabolism |
| MX2022001225A (es) | 2019-07-29 | 2022-03-17 | Brightseed Inc | Metodo para mejorar la salud digestiva. |
| MX2022005682A (es) | 2019-11-11 | 2022-08-08 | Brightseed Inc | Extracto, producto consumible y método para enriquecer metabolito bioactivo en un extracto. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| NL9001083A (nl) | 1990-05-04 | 1991-12-02 | Rijksuniversiteit | Beta-cel antigeen. |
| US5723286A (en) * | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
| DE69133393T2 (de) * | 1990-09-07 | 2005-06-16 | The Regents Of The University Of California, Oakland | Verfahren zur diagnose und behandlung von diabetes |
| US5674692A (en) * | 1991-09-06 | 1997-10-07 | Baekkeskov; Steinunn | Methods for diabetes susceptibility assessment in asymptomatic patients |
| ATE221200T1 (de) | 1993-04-16 | 2002-08-15 | Univ California | Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten |
-
1994
- 1994-04-08 AT AT94914094T patent/ATE221200T1/de not_active IP Right Cessation
- 1994-04-08 EP EP94914094A patent/EP0693183B1/de not_active Expired - Lifetime
- 1994-04-08 JP JP52334094A patent/JP3425149B2/ja not_active Expired - Fee Related
- 1994-04-08 WO PCT/US1994/003896 patent/WO1994024564A1/en not_active Ceased
- 1994-04-08 DE DE69431051T patent/DE69431051T2/de not_active Expired - Fee Related
-
1997
- 1997-09-25 US US08/937,955 patent/US6316209B1/en not_active Expired - Fee Related
-
2001
- 2001-11-13 US US09/993,371 patent/US6960448B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0693183A1 (de) | 1996-01-24 |
| US6960448B2 (en) | 2005-11-01 |
| US20050106633A1 (en) | 2005-05-19 |
| US6316209B1 (en) | 2001-11-13 |
| DE69431051T2 (de) | 2003-03-13 |
| JP3425149B2 (ja) | 2003-07-07 |
| EP0693183B1 (de) | 2002-07-24 |
| WO1994024564A1 (en) | 1994-10-27 |
| JPH08509289A (ja) | 1996-10-01 |
| EP0693183A4 (de) | 1998-04-29 |
| DE69431051D1 (de) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sowa et al. | Athletic participation: Its relationship to student development. | |
| Palfreyman et al. | Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury | |
| EP1491889A3 (de) | Verfahren zur Unterstützung der Diagnose der Alzheimerschen Krankheit durch Messung der Amyloid-Beta-Peptide(x =41) und Tau | |
| PL1625403T3 (pl) | Sposób przewidywania, diagnozowania i różnicowego diagnozowania choroby Alzheimera | |
| EP0764914A3 (de) | Verfahren zur Zuteilung von Betten auf einer pädiatrischen Intensivstation und zur Bewertung der Pflegequalität | |
| DE68927459D1 (de) | Nachweis einer neurologischen Krankheit oder einer Funktionsstörung | |
| DE69729654D1 (de) | Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit | |
| CA2142300A1 (en) | Methods for detecting alzheimer's disease | |
| SE9103332L (sv) | Metod foer diagnos av blodkoagulationssjukdomar | |
| ATE221200T1 (de) | Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten | |
| PL309637A1 (en) | Diagnostic test and therapy for demyelination diseases such as multiple sclerosis | |
| DK0568554T3 (da) | Fremgangsmåde til påvisning af anti-RNA-antistoffer | |
| CA2069611A1 (en) | Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals | |
| BLACK et al. | Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration | |
| ATE275268T1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| DK0788512T3 (da) | Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes | |
| EP0757105A3 (de) | Serumkennzeichenen zur Voraussage von Atemnotsyndrom bei Erwachsenen | |
| Petitti et al. | Physiologic measures in men with and without vasectomies | |
| MacKenzie et al. | Evaluating the abbreviated injury scale | |
| FI951778A0 (fi) | Menetelmä allergian toteamiseksi | |
| Sharp et al. | Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone | |
| Tull et al. | Incidence of childhood-onset IDDM in black African-heritage populations in the Caribbean | |
| Reisberg et al. | Global deterioration scale | |
| ATE229650T1 (de) | Verfahren zur diagnose von diabetes und praediabetischer bedingungen | |
| NO20002176D0 (no) | Diagnostikk og terapi av kronisk obstruktiv luftveissykdom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |